The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication

被引:11
|
作者
Van Cor-Hosmer, Sarah K. [1 ]
Daddacha, Waaqo [1 ]
Kelly, Z. [1 ]
Tsurumi, Amy [1 ]
Kennedy, Edward M. [1 ]
Kim, Baek [1 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14648 USA
关键词
HIV-1; Reverse transcriptase; dNTP binding affinity; Cellular dNTP pools; Steady and presteady kinetics; MURINE LEUKEMIA-VIRUS; DNA-SYNTHESIS; AMINO-ACID; DRUG-RESISTANCE; STERIC GATE; CELL-CYCLE; HIV-1; FIDELITY; LAMIVUDINE; MACROPHAGE;
D O I
10.1016/j.virol.2011.11.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) has a unique tight binding to dNTP substrates. Structural modeling of Ala-114 of HIV-1 RT suggests that longer side chains at this residue can reduce the space normally occupied by the sugar moiety of an incoming dNTP. Indeed, mutations at Ala-114 decrease the ability of RT to synthesize DNA at low dNTP concentrations and reduce the dNTP-binding affinity (K-d) of RT. However, the K-d values of WT and A114C RT remained equivalent with an acyclic dNTP substrate. Finally, mutant A114 RT HIV-1 vectors displayed a greatly reduced transduction in nondividing human lung fibroblasts (HLFs), while WT HIV-1 vector efficiently transduced both dividing and nondividing HLFs.Together these data support that the A114 residue of HIV-1 RT plays a key mechanistic role in the dNTP binding of HIV-1 RT and the unique viral infectivity of target cell types with low dNTP pools. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 50 条
  • [21] Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
    Kennedy, Edward M.
    Gavegnano, Christina
    Nguyen, Laura
    Slater, Rebecca
    Lucas, Amanda
    Fromentin, Emilie
    Schinazi, Raymond F.
    Kim, Baek
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (50) : 39380 - 39391
  • [22] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - AFFINITY LABELING OF THE PRIMER BINDING-SITE
    MITINA, RL
    DORONIN, SV
    DOBRIKOV, MI
    TABATADZE, DR
    LEVINA, AS
    LAVRIK, OI
    FEBS LETTERS, 1992, 312 (2-3) : 249 - 251
  • [23] STRUCTURE OF THE BINDING-SITE FOR NONNUCLEOSIDE INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMERDON, SJ
    JAGER, J
    WANG, J
    KOHLSTAEDT, LA
    CHIRINO, AJ
    FRIEDMAN, JM
    RICE, PA
    STEITZ, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3911 - 3915
  • [24] INITIAL BINDING OF 2'-DEOXYNUCLEOSIDE 5'-TRIPHOSPHATES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    PAINTER, GR
    WRIGHT, LL
    HOPKINS, S
    FURMAN, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (29) : 19362 - 19368
  • [25] STRUCTURAL REQUIREMENTS FOR THE BINDING OF TRNA(3)(LYS) TO REVERSE-TRANSCRIPTASE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESSINK, BBO
    DAS, AT
    BERKHOUT, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23867 - 23874
  • [26] Human immunodeficiency virus type-1 reverse transcriptase - Contribution of Met-184 to binding of nucleoside 5'-triphosphate
    Wilson, JE
    Aulabaugh, A
    Caligan, B
    McPherson, S
    Wakefield, JK
    Jablonski, S
    Morrow, CD
    Reardon, JE
    Furman, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) : 13656 - 13662
  • [27] INTERACTION BETWEEN RIFABUTIN AND HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 - INHIBITION OF REPLICATION, CYTOPATHIC EFFECT, AND REVERSE-TRANSCRIPTASE INVITRO
    ANAND, R
    MOORE, JL
    CURRAN, JW
    SRINIVASAN, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) : 684 - 688
  • [28] RNA PSEUDOKNOTS THAT INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    TUERK, C
    MACDOUGAL, S
    GOLD, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) : 6988 - 6992
  • [29] THE STRUCTURE OF UNLIGANDED REVERSE-TRANSCRIPTASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    RODGERS, DW
    GAMBLIN, SJ
    HARRIS, BA
    RAY, S
    CULP, JS
    HELLMIG, B
    WOOLF, DJ
    DEBOUCK, C
    HARRISON, SC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) : 1222 - 1226
  • [30] NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS AND RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    JOHNSON, VA
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 : S140 - S149